Abstract
Antisocial personality disorder (APD) is partly defined by the history of violent behaviour (DSM-IV), and psychopathy is known to be associated with violent crime (Hare, 1996; Hare & McPherson, 1984). Psychopathy is a term that had been used rather loosely until Cleckley (1976) endowed it with specific content, conceptual framework, and clinical descriptions. Hare and his group have developed the concept and provided several versions of a diagnostic instrument—the Psychopathy Checklist. The version most frequently used in criminal offender populations is called the Hare Psychopathy Checklist-Revised (PCL-R); this is a 20-item rating scale. A cut-off score of 30 (or 25 by some authors) implies the diagnosis of psychopathy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Atre-Vaidya, N., & Taylor, M.A. (1989). Effectiveness of lithium in schizophrenia: Do we really have an answer? Journal of Clinical Psychiatry, 50, 170–173.
Bergeman, C.S., & Seroczynski, A.D. (1998). Genetic and environmental influences on aggression and impulsivity. In M. Maes & E.F. Coccaro (Eds), Neurobiology and clinical views on aggression and impulsivity (pp. 63–80). Chichester: Wiley.
Buckley, P., Bartell, J., Donenwirth, K., Lee, S., Torigoe, F., & Schulz, S.C. (1995). Violence and schizophrenia: Clozapine as a specific antiaggressive agent Bulletin of the American Academy of Psychiatry and the Law, 23, 607–611.
Buckley, P.F., Ibrahim, Z.Y., Singer, B., On, B., Donenwirth, K., & Brar, P.S. (1997). Aggression and schizophrenia: Efficacy of risperidone. Journal of the American Academy of Psychiatry and the Law, 25, 173–181.
Cantillon, M., Arvanitis, L.A., Miller, B.G., & Kowalcyk, B.B. (1997, December). “Seroquel” (quetiapine fumarate) reduces hostility and aggression in patients with acute schizophrenia [Abstract]. Paper presented at the 36th annual meeting of the American College of Neuropsychopharmacology, 171.
Chiles, J.A., Davidson, P., & McBride, D. (1994). Effects of clozapine on use of seclusion and restraint at a state hospital. Hospital and Community Psychiatry, 45, 269–271.
Citrome, L. (1989). Differential diagnosis of psychosis: A brief guide for the primary care physician. Postgraduate Medicine, 85, 273–274.
Citrome, L. (1995). Use of lithium, carbamazepine, and valproic acid in a state-operated psychiatric hospital. Journal of Pharmacy Technology, 11, 55–59.
Citrome, L., Levine, J., & Allingham, B. (1998). Utilization of valproate: Extent of inpatient use in the New York State Office of Mental Health. Psychiatric Quarterly, 69, 283–300.
Citrome, L., & Volavka, J. (1997). Psychopharmacology of violence. Part II: Beyond the acute episode. Psychiatric Annals, 27, 696–703.
Citrome, L., & Volavka, J. (1998). The efficacy of pharmacological treatments in preventing crime and violence among persons with psychotic disorders. In S. Hodgins & R. MüIsberner (Eds.), Violence, crime, and mentally disordered offenders: Concepts and methods for effective treatment and prevention. New York: Wiley.
Citrome, L., & Volavka, J. (1999). Schizophrenia: Violence and comorbidity. Current Opinion in Psychiatry, 12, 47–51.
Cleckley, H. (1976). The mask of sanity (5th ed.). St. Louis: Mosby.
Coccaro, E.F., & Kavoussi, R.J. (1997). Fluoxetine and impulsive aggressive behavior in personality-disordered subjects. Archives of General Psychiatry, 54, 1081–1088.
Coccaro, E.F., Kavoussi, R.J., Cooper, T.B., & Hauger, R.L. (1997). Central serotonin activity and aggression: Inverse relationship with prolactin response to D-fenfluramine, but not CSF 5-HIAA concentration, in human subjects. American Journal of Psychiatry, 154, 1430–1435.
Collins, P.J., Larkin, E.P., & Shubsachs, A.P.W. (1991). Lithium carbonate in chronic schizophrenia: A brief trial of lithium carbonate added to neuroleptics for treatment of resistant schizophrenic patients. Acta Psychiatrica Scandinavica, 84, 150–154.
Convit, A., Isay, D., Otis, D., & Volavka, J. (1990). Characteristics of repeatedly assaultive psychiatric inpatients. Hospital and Community Psychiatry, 41, 1112–1115.
Côté, G., & Hodgins, S. (1990). Co-occurring mental disorders among criminal offenders. Bulletin of the American Academy of Psychiatry and the Law, 18, 271–281.
Crowner, M.L., Douyon, R., Convit, A., Gaztanaga, P., Volavka, J., & Bakall, R. (1990). Akathisia and violence. Psychopharmacology Bulletin, 26, 115–117.
Czobor, P., Volavka, J., & Meibach, R.C. (1995). Effect of risperidone on hostility in schizophrenia. Journal of Clinical Psychopharmacology, 15, 243–249.
Donovan, S.J., Susser, E.S., Nunes, E.V., Stewart, J.W., Quitkin, F.M., & Klein, D.F. (1997). Divalproex treatment of disruptive adolescents: A report of 10 cases. Journal of Clinical Psychiatry, 58, 12–15.
Ebrahim, G.M., Gibier, B., Gacono, C.B., & Hayes, G. (1994). Patient response to clozapine in a forensic psychiatric hospital. Hospital and Community Psychiatry, 45, 271–273.
Frances, A., Docherty, J.P., & Kahn, D.A. (1996). The expert consensus guideline series. Treatment of schizophrenia. Journal of Clinical Psychiatry, 57(Suppl 12B), 1–58.
Freese, A., Müller-Isberner, R., & Jockel, D. (1995). Psychopathy and co-morbidity in a German hospital order population [Abstract]. Issues in Criminological and Legal Psychology, 24, 45–46.
Geracioti, T.D. Jr. (1994). Valproic acid treatment of episodic explosiveness related to brain injury [letter]. Journal of Clinical Psychiatry, 55, 416–417.
Giakas, W.J., Seibyl, J.P., & Mazure, C.M. (1990). Valproate in the treatment of temper outbursts [letter]. Journal of Clinical Psychiatry, 51, 525.
Goldman, M.B., & Janecek, H.M. (1990). Adjunctive fluoxetine improves global function in chronic schizophrenia. Journal of Neuropsychiatry and Clinical Neurosciences, 2, 429–431.
Guy, W. (1986). ECDEU assessment manual for psychopharmacology. Rockville, MD: National Institute of Mental Health.
Hakola, H.P.A., & Laulumaa, V.A. (1982). Carbamazepine in treatment of violent schizophrenics [letter]. Lancet, 1, 1358.
Hallikainen, T., Saito, T., Lachman, H.M., Volavka, J., Pohjalainen, T., Ryynänen, 0.-P., Kauhanen, J., Syvalahti, E., Hietala, J., & Tiihonen, J. (in press). Association between low activity serotonin transporter promoter genotype with habitual impulsive behavior among antisocial early onset alcoholics. Molecular Psychiatry.
Hare, R.D. (1980). A research scale for the assessment of psychopathy in criminal populations. Personality and Individual Differences, I, 111–119.
Hare, R.D. (1996). Psychopathy and antisocial personality disorder: A case of diagnostic confusion. Psychiatric Times, February, 39–40.
Hare, R.D., & McPherson, L.M. (1984). Violent and aggressive behavior by criminal psychopaths. International Journal of Law and Psychiatry, 7, 35–50.
Hart, S.D., Hare, R.D., & Forth, A.E. (1994). Psychopathy as a risk marker for violence: Development and validation of a screening version of the revised psychopathy checklist. In J. Monahan & H.J. Steadman (Eds), Violence and mental disorder: Developments in risk assessment (pp. 81–98). Chicago: University of Chicago Press.
Hodgins, S., & Côté, G. (1993). Major mental disorder and antisocial personality disorder: A criminal combination. Bulletin of the American Academy of Psychiatry and the Law, 21, 155–160.
Hodgins, S., Côté, G., & Toupin, J. (1998). Major mental disorders and crime: An etiological hypothesis. In D. Cooke, A. Forth, & R.D. Hare (Eds), Psychopathy: Theory, research and implications for society (pp. 231–256). Dordrecht: Kluwer.
Hollander, E., Grossman, R., Stein, D.J., & Kwon, J. (1996). Borderline personality disorder and impulsive-aggression: The role for divalproex sodium treatment. Psychiatric Annals (Suppl 26), 5464–5469.
Honigfeld, G., & Klett, G. (1965). The nurses’ observation scale for inpatient evaluation: A new scale for measuring improvement in chronic schizophrenia. Journal of Clinical Psychology, 21, 65–71.
Home, M., & Lindley, S.E. (1995). Divalproex sodium in the treatment of aggressive behavior and dysphoria in patients with organic brain syndromes [letter]. Journal of Clinical Psychiatry, 56, 430–431.
Karson, C.N., Weinberger, D.R., Bigelow, L., & Wyatt, R.J. (1982). Clonazepam treatment of chronic schizophrenia: Negative results in a double-blind, placebo-controlled trial. American Journal of Psychiatry, 139, 1627–1628.
Kay, S.R., Fiszbein, A., & Opler, L.A. (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13, 261–276.
Keckich, W.A. (1978). Neuroleptics: Violence as a manifestation of akathisia Journal of the American Medical Association, 240, 2185–2185.
Krakowski, M.I., Convit, A., Jaeger, J., Lin, S., & Volavka, J. (1989a). Neurological impairment in violent schizophrenic inpatients. American Journal of Psychiatry, 146, 849–853.
Krakowski, M.I., Convit, A., Jaeger, J., Lin, S., & Volavka, J. (1989b). Inpatient violence: Trait and state. Journal of Psychiatric Research, 23, 57–64.
Krakowski, M.I., Kunz, M., Czobor, P., & Volavka, J. (1993). Long-term high-dose neuroleptic treatment: Who gets it and why? Hospital and Community Psychiatry, 44, 640–644.
Lachman, H.M., Nolan, K.A., Mohr, P., Saito, T., & Volavka, J. (1998). Association between catechol-O-methyltransferase genotype and violence in schizophrenia and schizoaffective disorder. American Journal of Psychiatry, 155, 835–837.
Lott, A.D., McElroy, S.L., & Keys, M.A. (1995). Valproate in the treatment of behavioral agitation in elderly patients with dementia. Journal of Neuropsychiatry and Clinical Neurosciences, 7, 314–319.
Luchins, D.J. (1984). Carbamazepine in violent non-epileptic schizophrenics. Psychopharmacology Bulletin, 20, 569–571.
Maier, G.J. (1992). The impact of clozapine on 25 forensic patients. Bulletin of the American Academy of Psychiatry and the Law, 20, 297–307.
MaIlya, A.R., Roos, P.D., & Roebuck-Colgan, K. (1992). Restraint, seclusion, and clozapine. Journal of Clinical Psychiatry, 53, 395–397.
Marder, S.R., Davis, J.M., & Chouinard, G. (1997). The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: Combined results of the North American trials. Journal of Clinical Psychiatry, 58, 538–546.
Mattes, J.A. (1992). Valproic acid for nonaffective aggression in the mentally retarded. Journal of Nervous and Mental Diseases, 180, 601–602.
Mazure, C.M., Druss, B.G., & Cellar, J.S. (1992). Valproate treatment of older psychotic patients with organic mental syndromes and behavioral dyscontrol. Journal of the American Geriatrics Society, 40, 914–916.
Mellow, A.M., Solano-Lopez, C., & Davis, S. (1993). Sodium valproate in the treatment of behavioral disturbance in dementia. Journal of Geriatric Psychiatry and Neurology, 6, 205–209.
Michals, M.L., Crismon, M.L., Roberts, S., & Childs, A. (1993). Clozapine response and adverse effects in nine brain-injured patients. Journal of Clinical Psychopharmacology, 13, 198–203.
Mueser, K.T., Drake, R.E., Ackerson, T.H., Alterman, A.I., Miles, K.M., & Noordsy, D.L. (1997). Antisocial personality disorder, conduct disorder, and substance abuse in schizophrenia. Journal of Abnormal Psychology, 106, 473–477.
Nedopil, N., Hollweg, M., Hartmann, J., & Jaser, R. (1998). Comorbidity of psychopathy with major mental disorders. In D.J. Cooke, A. Forth, & R.D. Hare (Eds.), Psychopathy: Theory, research and implications for society (pp. 257–268). Dordrecht: Kluwer.
Neppe, V.M. (1983). Carbamazepine as adjunctive treatment in nonepileptic chronic inpatients with EEG temporal lobe abnormalities. Journal of Clinical Psychiatry, 44, 326–331.
Nolan, K.A., Volavka, J., Mohr, P., & Czobor, P. (1999). Psychopathy and violent behavior among patients with schizophrenia or schizoaffective disorder. Psychiatric Services, 50, 787–792.
Okuma, T., Yamashita, I., Takahashi, R., Itoh, H., Otsuki, S., Watanabe, S., Sarai, K., Hazama, H., & Inanaga, K. (1989). A double-blind study of adjunctive carbamazepine versus placebo on excited states of schizophrenic and schizoaffective disorders. Acta Psychiatrica Scandinavica, 80, 250–259.
Owen, C., Tarantello, C., Jones, M., & Tennant, C. (1998). Repetitively violent patients in psychiatric units. Psychiatric Services, 49, 1458–1461.
Prakash, R. (1985). Lithium-responsive schizophrenia: Case reports. Journal of Clinical Psychiatry, 46, 141–142.
Rabinowitz, J., Avnon, M., & Rosenberg, V. (1996). Effect of clozapine on physical and verbal aggression. Schizophrenia Research, 22, 249–255.
Rasmussen, K., Levander, S., & Sletvold, H. (1995). Aggressive and non-aggressive schizophrenics: Symptom profile and neuropsychological differences. Psychology, Crime and Law, 2, 119–129.
Ratey, J.J., Leveroni, C., Kilmer, D., Gutheil, C., & Swartz, B. (1993). The effects of clozapine on severely aggressive psychiatric inpatients in a state hospital. Journal of Clinical Psychiatry, 54, 219–223.
Ratey, J.J., Sorgi, P., O’Driscoll, G.A., Sands, S., Daehler, M.L., Fletcher, J.R., Kadish, W., Spruiell, G., Polakoff, S., Lindem, K.J., Bemporad, J.R., Richardson, L., & Rosenfeld, B. (1992). Nadolol to treat aggression and psychiatric symptomatology in chronic psychiatric inpatients: A double-blind, placebo-controlled study. Journal of Clinical Psychiatry, 53, 41–46.
Ryback, R., & Ryback, L. (1995). Gabapentin for behavioral dyscontrol [Letter]. American Journal of Psychiatry, 152, 1399.
Schaffer, C.B., & Schaffer, L.C. (1997). Gabapentin in the treatment of bipolar disorder [Letter]. American Journal of Psychiatry, 154, 291–292.
Scott, H., Johnson, S., Menezes, P., Thornicroft, G., Marshall, J., Bindman, J., Bebbington, P., & Kuipers, E. (1998). Substance misuse and risk of aggression and offending among the severely mentally ill. British Journal of Psychiatry, 172, 345–350.
Sheard, M.H. (1971). Effect of lithium on human aggression. Nature, 230, 113–114.
Sheard, M.H., Marini, J.L., Bridges, C.I., & Wagner, E. (1976). The effect of lithium on impulsive aggressive behavior in man. American Journal of Psychiatry, 133, 1409–1413.
Silver, J.M., Yudofsky, S.C., Kogan, M., & Katz, B.L. (1986). Elevation of thioridazine plasma levels by propranolol. American Journal of Psychiatry, 143, 1290–1292.
Sorgi, P.J., Ratey, J.J., & Polakoff, S. (1986). Beta-adrenergic blockers for the control of aggressive behaviors in patients with chronic schizophrenia. American Journal of Psychiatry, 143, 775–776.
Steadman, H.J., Mulvey, E.P., Monahan, J., Robbins, P.C., Appelbaum, P.S., Grisso, T., Roth, L.H., & Silver, E. (1998). Violence by people discharged from acute psychiatric inpatient facilities and by others in the same neighborhoods. Archives of General Psychiatry, 55, 393–401.
Strous, R.D., Bark, N., Parsia, S.S., Volavka, J., & Lachman, H.M. (1997). Analysis of a functional catechol-O-methyltransferase gene polymorphism in schizophrenia: Evidence for association with aggressive and antisocial behavior. Psychiatry Research, 69, 71–77.
Swanson, J.W. (1994). Mental disorder, substance abuse, and community violence: An epidemiological approach. In J. Monahan & H.J. Steadman (Eds.), Violence and mental disorder: Developments in risk assessment (pp. 101–136). Chicago: University of Chicago Press.
Swartz, M.S., Swanson, J.W., Hiday, V.A., Borum, R., Wagner, H.R., & Burns, B.J. (1998). Violence and severe mental illness: The effects of substance abuse and nonadherence to medication. American Journal of Psychiatry, 155, 226–231.
Tupin, J.P., Smith, D.B., Clanon, T.L., Kim, L.I., Nugent, A., & Groupe, A. (1973). The longterm use of lithium in aggressive prisoners. Comprehensive Psychiatry, 14, 311–317.
Vartiainen, H., Tiihonen, J., Putkonen, A., Koponen, H., Virkkunen, M., Hakola, P., & Lehto, H. (1995). Citalopram, a selective serotonin reuptake inhibitor, in the treatment of aggression in schizophrenia. Acta Psychiatrica Scandinavica, 91, 348–351.
Volavka, J. (1995). Neurobiology of violence. Washington: American Psychiatric Press.
Volavka, J., & Citrome, L. (1999). Atypical antipsychotics in the treatment of the persistently aggressive psychotic patient: Methodological concerns. Schizophrenia Research, 35, S23–S33.
Volavka, J., & Krakowski, M. (1989). Schizophrenia and violence. Psychological Medicine, 19, 559–562.
Volavka, J., Mohammad, Y., Vitrai, J., Connolly, M., Stefanovic, M., & Ford, M. (1995). Characteristics of state hospital patients arrested for offenses committed during hospitalization. Psychiatric Services, 46, 796–800.
Volavka, J., Zito, J.M., Vitrai, J., & Czobor, P. (1993). Clozapine effects on hostility and aggression in schizophrenia. Journal of Clinical Psychopharmacology, 13, 287–289.
Whitman, J.R., Maier, G.J., & Eichelman, B. (1987). Beta-adrenergic blockers for aggressive behavior in schizophrenia [letter]. American Journal of Psychiatry, 144, 538–539.
Wilcox, J. (1994). Divalproex sodium in the treatment of aggressive behavior. Annals of Clinical Psychiatry, 6, 17–20.
Wilson, W.H. (1992). Clinical review of clozapine treatment in a state hospital. Hospital and Community Psychiatry, 43, 700–703.
Wilson, W.H. (1993). Addition of lithium to haloperidol in non-affective, antipsychotic nonresponsive schizophrenia: A double blind, placebo controlled, parallel design clinical trial. Psychopharmacology, 111, 359–366.
Wilson, W.H., & Claussen, A.M. (1995). 18-month outcome of clozapine treatment for 100 patients in a state psychiatric hospital. Psychiatric Services, 46, 386–389.
Wroblewski, B.A., Joseph, A.B., Kupfer, J., & Kalliel, K. (1997). Effectiveness of valproic acid on destructive and aggressive behaviours in patients with acquired brain injury. Brain Injury, 11, 37–47.
Yassa, R., & Dupont, D. (1983). Carbamazepine in the treatment of aggressive behavior in schizophrenic patients: A case report. Canadian Journal of Psychiatry, 28, 566–568.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Volavka, J., Citrome, L. (2000). Pharmacological Interventions for Preventing Violence Among the Mentally Ill with Co-Occurring Personality Disorders. In: Hodgins, S. (eds) Violence among the Mentally III. NATO Science Series, vol 90. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-4130-7_11
Download citation
DOI: https://doi.org/10.1007/978-94-011-4130-7_11
Publisher Name: Springer, Dordrecht
Print ISBN: 978-0-7923-6438-2
Online ISBN: 978-94-011-4130-7
eBook Packages: Springer Book Archive